The majority of the genes that make up the Myc core signature (MCS), associated with lymphoma malignancy and progression51 were not further altered in EμMyc/Casp2−/− compared to EμMyc tumors (Fig. 7, Supplementary Table S8a). Here, MYC is linked to lymphoma.